DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

DIGITAL CONTENT

3 NEWS #PharmaBuzz

media
3 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

9DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Sar439859, 2114339-57-8, Sar-439859, Amcenestrant [inn], Amcenestrant [usan], Tbf1nhy02o

Molecular Formula

C₃₁H₃₀Cl₂FNO₃

Molecular Weight

554.5 g/mol

InChI Key

KISZAGQTIXIVAR-VWLOTQADSA-N

FDA UNII

TBF1NHY02O

Amcenestrant is an orally available, nonsteroidal selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, amcenestrant specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells.

1 2D Structure

Amcenestrant

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid

2.1.2 InChI

InChI=1S/C31H30Cl2FNO3/c32-23-8-12-27(29(33)18-23)28-4-1-3-21-17-22(31(36)37)7-11-26(21)30(28)20-5-9-24(10-6-20)38-25-13-16-35(19-25)15-2-14-34/h5-12,17-18,25H,1-4,13-16,19H2,(H,36,37)/t25-/m0/s1

2.1.3 InChI Key

KISZAGQTIXIVAR-VWLOTQADSA-N

2.1.4 Canonical SMILES

C1CC2=C(C=CC(=C2)C(=O)O)C(=C(C1)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)OC5CCN(C5)CCCF

2.1.5 Isomeric SMILES

C1CC2=C(C=CC(=C2)C(=O)O)C(=C(C1)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)O[C@H]5CCN(C5)CCCF

2.2 Other Identifiers

2.2.1 UNII

TBF1NHY02O

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Sar439859

2. 2114339-57-8

3. Sar-439859

4. Amcenestrant [inn]

5. Amcenestrant [usan]

6. Tbf1nhy02o

7. (s)-8-(2,4-dichlorophenyl)-9-(4-((1-(3-fluoropropyl)pyrrolidin-3-yl)oxy)phenyl)-6,7-dihydro-5h-benzo[7]annulene-3-carboxylic Acid

8. 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic Acid

9. 8-(2,4-dichlorophenyl)-9-[4-[[(3s)-1-(3-fluoropropyl)-3-pyrrolidinyl]oxy]phenyl]-6,7-dihydro-5h-benzocycloheptene-3-carboxylic Acid

10. 5h-benzocycloheptene-3-carboxylic Acid, 8-(2,4-dichlorophenyl)-9-(4-(((3s)-1-(3-fluoropropyl)-3-pyrrolidinyl)oxy)phenyl)-6,7-dihydro-

11. 6-(2,4-dichlorophenyl)-5-[4-[(3~{s})-1-(3-fluoranylpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7~{h}-benzo[7]annulene-2-carboxylic Acid

12. 8-(2,4-dichlorophenyl)-9-(4-(((3s)-1-(3-fluoropropyl)-3-pyrrolidinyl)oxy)phenyl)-6,7-dihydro-5h-benzocycloheptene-3-carboxylic Acid

13. Unii-tbf1nhy02o

14. Amcenestrant [jan]

15. Amcenestrant [who-dd]

16. Chembl4475463

17. Schembl19131426

18. Us9714221, Example 51

19. Bdbm263716

20. Ex-a4678

21. Nsc827675

22. S9609

23. Who 11312

24. Nsc-827675

25. Hy-133017

26. Cs-0109407

27. Q66885452

28. 8-(2,4-dichlorophenyl)-9-(4-(((3s)-1-(3-fluoropropyl)pyrrolidin-3-yl)oxy)phenyl)-6,7-dihydro-5h-benzo(7)annulene-3-carboxylic Acid

29. L5b

2.4 Create Date

2017-10-07

3 Chemical and Physical Properties

Molecular Formula	C₃₁H₃₀Cl₂FNO₃
Molecular Weight	554.5 g/mol
XLogP3	5.3
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	8
Exact Mass	553.1586774 g/mol
Monoisotopic Mass	553.1586774 g/mol
Topological Polar Surface Area	49.8 Å²
Heavy Atom Count	38
Formal Charge	0
Complexity	832
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1